MRM Health

Focus: MRM Health is a Belgium-based biotechnology company focused on microbiotic therapies, operating at Series B stage with a pipeline targeting microbiome-related diseases including Parkinson's disease and ulcerative colitis.

Microbiome

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

SERIES B

Open Jobs

About MRM Health

AI assessmentNot Hiring

No open roles listed right now. Follow MRM Health to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Fluid biopsy capsule

Parkinson Disease

N/A

Clinical Trials (1)

NCT06003608Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

N/A

Help build intelligence for MRM Health

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity in microbiome therapeutics, an emerging high-growth segment with significant unmet clinical need
Series B stage provides meaningful equity upside potential while retaining operational focus versus later-stage biotech
Specialized therapeutic area with limited competitor talent pools creates differentiated career positioning

Watch Out For

Only 2 active job openings signals minimal hiring momentum and limited near-term career mobility within the company
Pre-revenue stage with no disclosed financials creates visibility and cash-runway risk—sustainability unconfirmed
Very early pipeline with only 1 Phase 2 program and no Phase 3 data means clinical catalysts are years away

Generated by Claude from MRM Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Low-dose MH002

Colitis, Ulcerative

Phase 2

Clinical Trials (1)

NCT07296315Confirmatory Clinical Study in Active Ulcerative Colitis

Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Top TAs: Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

1 pipeline

Marketed

Pipeline